BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 30, 2014
View Archived Issues
Researchers design genome editing system to correct hereditary gene dysfunction
Read More
Chloroquine derivative developed for improving anticancer activity
Read More
Jubilant Biosys identifies compounds active against mutant EGFR
Read More
CCTA-1523 reverses ABCG2-mediated multidrug resistance in cancer cells
Read More
Scientists at Roche disclose novel benzimidazoles as CNS active agents
Read More
AbbVie presents highlights of first quarter 2014
Read More
Novel agent for neuropsychiatric disorders presented by IntraCellular Therapies
Read More
Novavax discloses data from phase II study of RSV vaccine
Read More
Sanofi patents novel protein kinase inhibitors for cancer
Read More
Researchers at Novartis present new capsular saccharides for immune responses
Read More
French researchers disclose new agents for HIV infection
Read More
Scientists at Orion Corp. design new TRPA1 antagonists
Read More
IMM-H007 reduces atherosclerotic plaque in mice and increases circulating HDL levels
Read More
Oxford BioMedica provides update on RetinoStat program
Read More
Preclinical results presented for InvaplexAR, a Shigella vaccine
Read More
GSK and MMV begin phase III program of tafenoquine
Read More
Amicus Therapeutics reports data from phase III trial of migalastat
Read More
Crinetics Pharmaceuticals receives grant to develop sst agonists for ophthalmic use
Read More
Glenmark's anti-TrkA antibody for chronic pain to enter phase I
Read More
AstraZeneca declines latest offer from Pfizer
Read More
Ambrx and Zhejiang Hisun form cancer collaboration
Read More
First approval of Otsuka's Deltyba for tuberculosis
Read More
Biota receives stop-work order on activities related to contract with BARDA
Read More
ReGenX and AAVLife sign license agreement in Friedreich's ataxia
Read More
Meda rejects Mylan merger proposal
Read More
Bristol-Myers Squibb acquires iPierian
Read More
FDA approves Zykadia for ALK+ non-small cell lung cancer
Read More